相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Joong-Won Park et al.
CLINICAL CANCER RESEARCH (2011)
Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
Anne-Christine Piguet et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
Claire Vanpouille-Box et al.
PLOS ONE (2011)
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
Yanming Zhou et al.
BMC GASTROENTEROLOGY (2010)
AZD6244 (ARRY-142886) Enhances the Antitumor Activity of Rapamycin in Mouse Models of Human Hepatocellular Carcinoma
Hung Huynh
CANCER (2010)
Irreversible Electroporation Therapy in the Liver: Longitudinal Efficacy Studies in a Rat Model of Hepatocellular Carcinoma
Yang Guo et al.
CANCER RESEARCH (2010)
Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Liang Liu et al.
CLINICAL CANCER RESEARCH (2010)
Stem Cell Origins and Animal Models of Hepatocellular Carcinoma
Rajagopal N. Aravalli et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Progenitor-Derived Hepatocellular Carcinoma Model in the Rat
Jesper B. Andersen et al.
HEPATOLOGY (2010)
A Meta-Analysis of Survival Rates of Untreated Patients in Randomized Clinical Trials of Hepatocellular Carcinoma
Giuseppe Cabibbo et al.
HEPATOLOGY (2010)
Epigenetic Silence of Ankyrin-Repeat-Containing, SH3-Domain-Containing, and Proline-Rich-Region-Containing Protein 1 (ASPP1) and ASPP2 Genes Promotes Tumor Growth in Hepatitis B Virus-Positive Hepatocellular Carcinoma
Jian Zhao et al.
HEPATOLOGY (2010)
CD151 Modulates Expression of Matrix Metalloproteinase 9 and Promotes Neoangiogenesis and Progression of Hepatocellular Carcinoma
Guo-Ming Shi et al.
HEPATOLOGY (2010)
Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis
Jian-Hong Zhong et al.
HEPATOLOGY RESEARCH (2010)
Animal models for hepatitis C and related liver disease
Kazuhiko Koike et al.
HEPATOLOGY RESEARCH (2010)
The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma
Yigang Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2010)
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
Giacomo Germani et al.
JOURNAL OF HEPATOLOGY (2010)
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2010)
The Hepatitis B Virus X Protein Modulates Hepatocyte Proliferation Pathways To Stimulate Viral Replication
Tricia L. Gearhart et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells
Bin Cheng et al.
LIVER INTERNATIONAL (2010)
Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis
Wei Wang et al.
LIVER INTERNATIONAL (2010)
Mouse Models of Hepatocellular Carcinoma
Nelson Fausto et al.
SEMINARS IN LIVER DISEASE (2010)
Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma
Terence C. Tang et al.
NEOPLASIA (2010)
Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites models of hepatocellular carcinoma
Jeng-Long Hsieh et al.
CANCER SCIENCE (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Xin-Rong Yang et al.
CLINICAL CANCER RESEARCH (2009)
Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma
H. Huynh et al.
CURRENT CANCER DRUG TARGETS (2009)
Capn4 Overexpression Underlies Tumor Invasion and Metastasis After Liver Transplantation for Hepatocellular Carcinoma
Dou-Sheng Bai et al.
HEPATOLOGY (2009)
Hepatitis B Virus X Protein Shifts Human Hepatic Transforming Growth Factor (TGF)-β Signaling from Tumor Suppression to Oncogenesis in Early Chronic Hepatitis B
Miki Murata et al.
HEPATOLOGY (2009)
Experimental mouse models for hepatocellular carcinoma research
Femke Heindryckx et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Experimental models of hepatocellular carcinoma: developments and evolution
Long Wu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis
Sun-Young Kim et al.
PROTEOMICS (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma
Tomonori Iida et al.
CANCER SCIENCE (2008)
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Hung Huynh et al.
CLINICAL CANCER RESEARCH (2008)
Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
Ying-Hong Shi et al.
HEPATOLOGY (2008)
Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma
Anne-Christine Piguet et al.
JOURNAL OF HEPATOLOGY (2008)
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2008)
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials
Pippa Newell et al.
JOURNAL OF HEPATOLOGY (2008)
Experimental models of hepatocellular carcinoma
Philippa Newell et al.
JOURNAL OF HEPATOLOGY (2008)
Generation and Modulation of Hepatocellular Carcinoma Circulating Cells: A New Experimental Model
Olivier Scatton et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Dual therapeutic effects of interferon-α gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis
Kai-Wen Huang et al.
MOLECULAR THERAPY (2008)
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
Patrick Arbuthnot et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Epidemiology of hepatocellular carcinoma in USA
Hashem B. El-Serag
HEPATOLOGY RESEARCH (2007)
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma
David Semela et al.
JOURNAL OF HEPATOLOGY (2007)
Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model
Ru-Xian Lin et al.
HEPATOLOGY RESEARCH (2007)
Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model
Tao Gu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model
Volker Schmitz et al.
GUT (2007)
A proteomics method revealing disease-related proteins in livers of hepatitis-infected mouse model
Tomoko Ichibangase et al.
JOURNAL OF PROTEOME RESEARCH (2007)
AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma
Hung Huynh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice
A. Salvi et al.
TUMOR BIOLOGY (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Xenografts of human hepatocellular carcinoma: A useful model for testing drugs
Hung Huynh et al.
CLINICAL CANCER RESEARCH (2006)
Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma
O. Scatton et al.
ONCOGENE (2006)
Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial
Hui-Chuan Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo
CR Jung et al.
HEPATOLOGY (2006)
Gene expression analysis in HBV transgenic mouse liver: A model to study early events related to hepatocarcinogenesis
Michele Barone et al.
MOLECULAR MEDICINE (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice
F Cui et al.
PROTEOMICS (2006)
RNA interference-mediated prevention and therapy for hepatocellular carcinoma
P. R. Romano et al.
ONCOGENE (2006)
Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice
Yuning Sun et al.
OLIGONUCLEOTIDES (2006)
Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose n-nitrosomorpholine and diethylnitrosamine
H Yoshino et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model
RX Lin et al.
ACTA PHARMACOLOGICA SINICA (2005)
Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma
HH Li et al.
GASTROENTEROLOGY (2005)
Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma
AL Stefani et al.
JOURNAL OF HEPATOLOGY (2005)
Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
F Graepler et al.
HEPATOLOGY (2005)
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis
Y Kamegaya et al.
HEPATOLOGY (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer et al.
HEPATOLOGY (2005)
Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model
A Maataoui et al.
EUROPEAN RADIOLOGY (2005)
A decade's studies on metastasis of hepatocellular carcinoma
ZY Tang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development
LR Kelland
EUROPEAN JOURNAL OF CANCER (2004)
HBs4g and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice
YL Wang et al.
HEPATOLOGY (2004)
c-Fos is a mediator of the c-Myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway
N Karla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
From proteomic analysis to clinical significance - Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis
SJ Ding et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Pathogenesis of hepatitis C-associated hepatocellular carcinoma
TJ Liang et al.
GASTROENTEROLOGY (2004)
Suppression of metastasis by nuclear factor kappa B inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma
M Futakuchi et al.
CANCER SCIENCE (2004)
Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma
M Singh et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye et al.
NATURE MEDICINE (2003)
Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation
R Lakhtakia et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China
L Ming et al.
HEPATOLOGY (2002)
Role of hepatitis C virus in the development of hepatocellular carcinoma: Transgenic approach to viral hepatocarcinogenesis
K Koike et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus
H Lerat et al.
GASTROENTEROLOGY (2002)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential
L Wang et al.
HEPATOLOGY (2000)
BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites
R Ray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)